Aura Biosciences, Inc. - 8-K Filing

Aura Biosciences appoints Jeremy Bender as Class II director effective July 7, 2026 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $AURA

Read the full article at SEC EDGAR

More Regulatory news